Literature DB >> 12089274

Use of a fragment of glycoprotein G-2 produced in the baculovirus expression system for detecting herpes simplex virus type 2-specific antibodies.

Minako Ikoma1, Jan-Ake Liljeqvist, Jan Groen, Koen L Glazenburg, T Hauw The, Sytske Welling-Wester.   

Abstract

Fragments of glycoprotein G (gG-2(281-594His)), comprising residues 281 to 594 of herpes simplex virus type 2 (HSV-2), glycoprotein G of HSV-1 (gG-1(t26-189His)), and glycoprotein D of HSV-1 (gD-1(1-313)), were expressed in the baculovirus expression system to develop an assay for the detection of HSV-1 and HSV-2 type-specific antibodies. The expression of the gG-1(t26-189His) and gG-2(281-594His) fragments was analyzed by Western blotting using monoclonal antibodies LP10 and AP1, respectively. The molecular masses of the major products of gG-1(t26-189His) and the fragment of gG-2(281-594His) were 36 to 39 kDa and 64 to 72 kDa, respectively. Human sera positive for HSV-1 reacted with gG-1(t26-189His), sera positive for HSV-2 reacted with the gG-2(281-594His) fragment, and sera positive for both types reacted with gG-1(t26-189His) and gG-2(281-594His) in Western blotting. The human sera recognized polypeptides of gG-2(281-594His) with molecular masses of 57 to 67 and 120 to 150 kDa and additional faint bands of 21, 29, and 45 kDa. The recombinant gG-1(t26-189His) and the recombinant gG-2(281-594His) fragment were used as type-specific antigens for the detection of HSV-1- and HSV-2-specific antibody responses in human sera, respectively. As type-common antigens, an extract of HSV-1-infected Vero cells and recombinant gD-1(1-313) were used. An enzyme-linked immunosorbent assay to detect type-specific antibodies was developed, and the sensitivity and specificity were evaluated by comparison with commercial tests by using sera obtained from different sources. The sensitivity and specificity were 91.5 and 95.5%, respectively, compared to the Gull assay. The gG-2(281-594His) fragment can be obtained in relatively large quantities at low cost.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089274      PMCID: PMC120576          DOI: 10.1128/JCM.40.7.2526-2532.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  57 in total

1.  Seroprevalence of herpes simplex virus type 2 infection among attendees of a sexually transmitted disease clinic in Italy. Italian Herpes Forum.

Authors:  M Cusini; M Cusan; C Parolin; L Scioccati; I Decleva; C Mengoli; B Suligoi; G Palú
Journal:  Sex Transm Dis       Date:  2000-05       Impact factor: 2.830

2.  Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection.

Authors:  R L Ashley; M Eagleton; N Pfeiffer
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

3.  The use of peptides from glycoproteins G-2 and D-1 for detecting herpes simplex virus type 2 and type-common antibodies.

Authors:  M Levi; U Rudén; H Carlberg; B Wahren
Journal:  J Clin Virol       Date:  1999-05       Impact factor: 3.168

4.  Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by the majority of patients infected with HSV-2, but not by those infected with HSV-1.

Authors:  A Grabowska; C Jameson; P Laing; S Jeansson; E Sj Gren-Jansson; J Taylor; A Cunningham; W L Irving
Journal:  J Gen Virol       Date:  1999-07       Impact factor: 3.891

5.  Antigenic cross-reactions among herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus.

Authors:  N Balachandran; D E Oba; L M Hutt-Fletcher
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

Review 6.  Antigenic differences between HSV-1 and HSV-2 glycoproteins and their importance for type-specific serology.

Authors:  T Bergström; E Trybala
Journal:  Intervirology       Date:  1996       Impact factor: 1.763

7.  Characterization of a herpes simplex virus type 2-specified glycoprotein with affinity for N-acetylgalactosamine-specific lectins and its identification as g92K or gG.

Authors:  S Olofsson; M Lundström; H Marsden; S Jeansson; A Vahlne
Journal:  J Gen Virol       Date:  1986-04       Impact factor: 3.891

8.  The genome sequence of herpes simplex virus type 2.

Authors:  A Dolan; F E Jamieson; C Cunningham; B C Barnett; D J McGeoch
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

Review 9.  Herpes simplex virus: the importance of asymptomatic shedding.

Authors:  D M Koelle; A Wald
Journal:  J Antimicrob Chemother       Date:  2000-04       Impact factor: 5.790

10.  Comparison of two enzyme-linked immunosorbent assays and one rapid immunoblot assay for detection of herpes simplex virus type 2-specific antibodies in serum.

Authors:  J Groen; G Van Dijk; H G Niesters; W I Van Der Meijden; A D Osterhaus
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

View more
  6 in total

1.  Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.

Authors:  S Q Wales; C C Smith; M Wachsman; G Calton; L Aurelian
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

2.  Production of a fragment of glycoprotein G of herpes simplex virus type 2 and evaluation of its diagnostic potential.

Authors:  Tao Liu; Ji Feng Liu; Hua Yu; Guo Jing Si; Jun Hu; Jun Li
Journal:  Singapore Med J       Date:  2015-06       Impact factor: 1.858

3.  Production of herpes B virus recombinant glycoproteins and evaluation of their diagnostic potential.

Authors:  Ludmila Perelygina; Irina Patrusheva; Soumya Hombaiah; Holley Zurkuhlen; Martin J Wildes; Nikolai Patrushev; Julia Hilliard
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

4.  An automated ELISA using recombinant antigens for serologic diagnosis of B virus infections in macaques.

Authors:  David Katz; Wei Shi; Irina Patrusheva; Ludmila Perelygina; Manjunath S Gowda; Peter W Krug; Chadi N Filfili; John A Ward; Julia K Hilliard
Journal:  Comp Med       Date:  2012-12       Impact factor: 0.982

5.  Secreted portion of glycoprotein g of herpes simplex virus type 2 is a novel antigen for type-discriminating serology.

Authors:  Staffan Görander; Bo Svennerholm; Jan-Ake Liljeqvist
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

6.  Expression of variable viruses as herpes simplex glycoprotein D and varicella zoster gE glycoprotein using a novel plasmid based expression system in insect cell.

Authors:  A M Al-Sulaiman; P J Vallely; P E Klapper; Raid Al Baradie; Shaihana Abdulrahman Almatrrouk; Khalid K Alharbi
Journal:  Saudi J Biol Sci       Date:  2016-05-10       Impact factor: 4.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.